Thank you for your continuing support of Health and Global Policy Institute (HGPI).
We would like to share with you the top five most read recommendations and reports from the first quarter of fiscal year 2025.

---

[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)

Dr. Ataru Igarashi, an HGPI Fellow, has created a set of policy recommendations entitled, “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan.”

These recommendations are being released as a part of Health and Global Policy Institute (HGPI)’s recently launched “HGPI Expert Policy Advocacy Platform,” which will facilitate the creation and promotion of policy recommendations by HGPI fellows and others associated with the Institute. Through this platform, policy recommendations developed by HGPI Fellows and others are scrutinized and approved by a review committee within HGPI. Upon their approval, HGPI commits to issuing and advocating for the proposals. It is hoped that this new platform will produce a wide variety of both feasible and creative solutions to today’s pressing health policy issues.

---

[Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care”

This report focuses on addressing regional disparities in breast cancer care by analyzing issues in Japan’s current healthcare system and identifying the challenges unique to breast cancer. It proposes policy measures that not only address for breast cancer but that are generalizable to other types of cancer, and that address healthcare disparities. To address regional disparities in breast cancer care, discussions among experts centered on three key perspectives: Sustainable healthcare delivery systems, Implementation of the PDCA cycle for quality improvement, and Patient participation and comprehensive support.

---

[Research Report] The 2025 Public Opinion Survey on Healthcare in Japan

HGPI conducted a nationwide public opinion survey of 1,000 men and women age 20 years and over. This year’s survey also asked about access to healthcare institutions and medicines in light of recent developments like work-style reform for physicians and the launch of the system for patient-selected extra medical services. Furthermore, in December 2024, Japan stopped issuing new insurance cards and began full-scale efforts to transition to the use of My Number cards in their place. Expectations are high for this change to help centralize medical information and advance digital transformation (DX). Given these circumstances, this year’s survey also examined public awareness of the use of medical information.

---

[Event Report] Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration”

HGPI held a public symposium titled “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” on August 28, 2024, the report from this symposium has been released.

---

[Policy Recommendation] Ensuring Equitable Access to Cancer Gene Panel Testing and Key Considerations for Applying the Mixed Medical Services Program

HGPI have released a new policy recommendation on improving patient access to cancer gene panel testing in Japan.
Our proposal examines systemic barriers under current reimbursement policies and provides three key perspectives for reform, including the implications of the Mixed Medical Services Program.

---

In addition to those featured here, we have published recommendations and reports for each of our projects. On Our website, you can find the recommendations and reports we have published up to now, project by project and fiscal year by fiscal year.